1. Academic Validation
  2. Targeted Inhibition of FTO Demethylase Protects Mice Against LPS-Induced Septic Shock by Suppressing NLRP3 Inflammasome

Targeted Inhibition of FTO Demethylase Protects Mice Against LPS-Induced Septic Shock by Suppressing NLRP3 Inflammasome

  • Front Immunol. 2021 May 4;12:663295. doi: 10.3389/fimmu.2021.663295.
Jiahui Luo 1 Faxi Wang 1 Fei Sun 1 Tiantian Yue 1 Qing Zhou 1 Chunliang Yang 1 Shanjie Rong 1 Ping Yang 1 Fei Xiong 1 Qilin Yu 1 Shu Zhang 1 Cong-Yi Wang 1 Jinxiu Li 2
Affiliations

Affiliations

  • 1 The Center for Biomedical Research, NHC Key Laboratory of Respiratory Diseases, Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • 2 Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Abstract

Sepsis refers to the systemic inflammatory response syndrome caused by Infection. It is a major clinical problem and cause of death for patients in intensive care units worldwide. The Fat mass and obesity-related protein (FTO) is the primary N6-methyladenosine demethylase. However, the role of FTO in the pathogenesis of inflammatory diseases remains unclear. We herein show that nanoparticle-mediated Fto-siRNA delivery or FTO inhibitor entacapone administration dramatically inhibited macrophage activation, reduced the tissue damage and improved survival in a mouse model of LPS-induced endotoxic shock. Importantly, ablation of FTO could inhibit NLRP3 inflammasome through FoxO1/NF-κB signaling in macrophages. In conclusion, FTO is involved in inflammatory response of LPS-induced septic shock and inhibition of FTO is promising for the treatment of septic shock.

Keywords

FTO; N6-methyladenosine; entacapone; inflammasome; sepsis.

Figures
Products